Search Bar & Filters
Found 20 Actively Recruiting clinical trials
Actively Recruiting
Researchers are comparing two treatment combinations for adults with advanced nonsquamous non-small cell lung cancer NSCLC that is stage IV or advanced stage IIIBC, specifically with a KRAS p.G12C mutation and no PD-L1 expression. The study evaluates progression-free survival and overall survival between participants receiving sotorasib with chemotherapy and those receiving pembrolizumab with chemotherapy. This is a phase 3, randomized, open-label study aiming to find which frontline therapy might better manage this type of lung cancer. Participants are randomly assigned to one of two groups one group receives sotorasib orally combined with carboplatin and pemetrexed chemotherapy, and the other group receives pembrolizumab given intravenously combined with the same chemotherapy agents. Treatments are given as front-line therapy for their cancer. The study measures the effects of these combinations over time, including tumor response and quality of life changes. During the study, participants will be closely monitored for progression-free survival, overall survival, and other outcomes related to tumor response and quality of life through questionnaires. Researchers will track treatment-emergent adverse events, vital signs, and lab tests to evaluate safety. The study includes follow-up assessments for up to approximately 5.5 years, allowing comprehensive evaluation of long-term outcomes and side effects. Participant involvement includes regular visits for treatment administration and assessments throughout the study period.
Actively Recruiting
Researchers are evaluating camizestrant compared to standard endocrine therapy in patients with ER-positive, HER2-negative early breast cancer who have an intermediate or high risk of disease recurrence. This Phase III open-label study includes patients who have completed definitive locoregional therapy, with or without chemotherapy, and have received standard adjuvant endocrine therapy for at least 2 years and up to 5 years. The study aims to determine if camizestrant improves invasive breast cancer-free survival and other important outcomes over a long-term follow-up. Participants will be randomly assigned to receive either camizestrant orally or continue standard endocrine therapy chosen by their doctor, which may include aromatase inhibitors like exemestane, letrozole, anastrozole, or tamoxifen. Treatment in both groups will last for up to 60 months. The study allows prior use of CDK46 inhibitors and includes an open-label design where both participants and researchers know the assigned treatment. During the study, participants will be monitored with assessments including survival outcomes, disease-free survival, relapse-free survival, and overall survival for up to 10 years from the last patient randomized. Safety will be tracked through adverse event reporting, laboratory and vital signs tests, and symptom questionnaires measuring arthralgia, hot flushes, vaginal dryness, and quality of life. Pharmacokinetics will be studied up to 6 months after treatment starts. The total duration of participation can extend over many years to capture long-term results.
Actively Recruiting
Researchers are evaluating the addition of Tersolisib LY4064809STX-478 to other anti-cancer drugs as a first treatment for adults with advanced hormone receptor-positive HR and human epidermal growth factor receptor 2-negative HER2- breast cancer that has a PIK3CA genetic mutation. The study aims to assess the effectiveness and safety of this combination in people whose cancer cannot be cured by surgery alone. Participants may continue in the study as long as the treatment is helping and side effects are manageable. Participants will be randomly assigned to one of three groups two different doses of Tersolisib combined with a CDK46 inhibitor and endocrine therapy ET, or a placebo combined with the same drugs. The CDK46 inhibitor and ET are given orally or intramuscularly depending on the drug chosen by the investigator. Treatments are administered orally or by injection as appropriate. The study includes a phase 2 dose optimization portion and a phase 3 randomized, double-blind, placebo-controlled portion. During the study, participants will undergo regular assessments including scans and tests to measure tumor response and progression. Researchers will monitor overall response rate, progression-free survival, and other health outcomes for up to 5 to 7 years. Safety and drug levels in the blood will also be tracked. Participants quality of life and physical function will be evaluated using questionnaires. The total time in the study depends on individual treatment response and side effects.
Actively Recruiting
This research aims to evaluate the safety, performance, and usability of several Occlutech accessory medical devices used in heart disease treatment. These devices include the Occlutech Delivery Set ODS, Occlutech Pistol Pusher OPP, Occlutech Occlusions-Pusher OOP, and Occlutech Sizing Balloon OSB. The study is international, multicenter, non-randomized, and non-invasive, focusing on catheter-based implantation procedures for cardiac implants. The study involves physicians experienced in cardiac catheterization using these accessories during implantation procedures. Investigators complete detailed surveys to assess each devices safety, including success of implantation, adverse events during or after the procedure, user harm, and any device deficiencies. The surveys also evaluate the performance, usability, and compatibility of these accessories with other devices. Subjects receive treatment following standard clinical routines and specific instructions for use. Participants who have undergone implantation with an Occlutech accessory and cardiac implant are included. Researchers monitor safety events and assess device performance and usability over a 6-month period. Data is collected via investigator questionnaires, focusing on implantation outcomes and any related complications. The total participation duration varies depending on individual follow-up but includes at least 6 months of monitoring for safety and performance.
Actively Recruiting
Researchers are studying children aged 6 months to 5 years who have acute gastroenteritis, a common cause of dehydration and emergency visits. The study compares two types of intravenous fluids used for rehydration normal saline, which has a high chloride content, and balanced crystalloids like Isolyte-S, which contain acetate and gluconate to help neutralize acid. The goal is to see if balanced fluids improve blood bicarbonate levels and other clinical outcomes compared to normal saline. The study observes children who receive either normal saline or the balanced crystalloid Isolyte-S as part of their routine care, with the treating physician deciding which fluid to use independently. No additional tests or treatments are given for research purposes. Data are collected at baseline when fluids start, about 4 hours later from routine blood tests, and 72 hours after discharge to check for return visits. During participation, childrens blood tests taken as part of standard care are reviewed to evaluate changes in serum bicarbonate, blood pH, chloride levels, and other measures like time to first oral intake and hospital admission. Researchers also track if additional IV fluid boluses are needed and monitor for emergency return visits within 72 hours. The study lasts through these observation points without extra procedures beyond usual care.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the current risk of tooth decay in children who had dental treatment under general anesthesia for early childhood caries ECC between 2015 and 2020 at Ayd31n Adnan Menderes University. This observational, cross-sectional study focuses on systemically healthy children aged 6 to 16 years. The goal is to better understand caries risk profiles to support long-term prevention and oral health policies for children treated under anesthesia for ECC. Participants will undergo a single visit where their caries risk is assessed using the Cariogram model. This model combines clinical dental measures like decayed, missing, or filled teeth DMFTdmft, plaque and gingival health, probing depth, and salivary factors such as stimulated flow rate and buffering capacity. Standardized questionnaires will also gather information on diet, fluoride use, socioeconomic status, and dental history. No treatments will be given during the study data is collected solely for analysis. During the study visit, children will have clinical dental exams, saliva tests, and complete questionnaires. Researchers will measure caries risk and related factors including plaque index, gingival index, and fluoride exposure. Data analysis will use statistical software. The studys findings aim to guide better monitoring and prevention strategies for children at high risk of caries after treatment under general anesthesia, helping to shape future oral health care and policy.
Actively Recruiting
Researchers are studying children aged 1 month to 18 years who are receiving mechanical ventilation due to acute respiratory failure or pediatric respiratory distress syndrome. The study aims to compare the safety and effectiveness of a closed-loop synchronization controller with conventional manual synchronization during invasive mechanical ventilation of spontaneous breathing pediatric patients in a pediatric intensive care unit PICU. The trial involves two treatment periods, each lasting one hour. In one period, the pressure support of the childs spontaneous breathing will be automatically adjusted by the closed-loop synchronization controller using analysis of pressure and flow waveforms. In the other period, the pressure support will be manually set using conventional synchronization settings. This is a randomized crossover study where participants receive both interventions. During the study, researchers will monitor and measure the asynchrony index, major and minor asynchronies, comfort behavioral score, air leak, oxygen saturation SpO2, and end-tidal carbon dioxide EtCO2 during each one-hour treatment period. The trial involves close observation and evaluation of how well the synchronization methods support the childs breathing while minimizing asynchrony and discomfort.
Actively Recruiting
Healthy Volunteer
This research aims to compare the clinical success and parental satisfaction of prefabricated stainless steel crowns and zirconia crowns used on childrens primary mandibular second molars after pulpotomy treatment for deep, multi-surface caries. The study focuses on dental caries and pulpotomy, assessing how these two crown types affect periodontal health, plaque buildup, tooth wear, and various clinical performance factors such as color match and retention. Two groups of children aged 4 to 5 years will receive either a prefabricated stainless steel crown or a zirconia crown on opposite primary mandibular second molars using a split-mouth design. Treatments include pulpotomy followed by crown preparation and cementation using specific dental materials and procedures. The crowns will be cemented with FujiCEM Evolve, and detailed preparation methods differ between the two crown types to ensure proper fit. The study will continue until all follow-up visits are completed and data finalized. Participants will be evaluated at baseline, then at 1, 3, 6, and 12 months after treatment. Assessments include periodontal health indexes, plaque accumulation, opposing tooth wear, and clinical performance measures such as marginal integrity and postoperative sensitivity. Parental satisfaction will also be measured at these intervals. Intraoral photographs will be taken immediately after treatment and during each follow-up to document changes. The study monitors for clinical success factors and potential failures such as crown decementation or tooth abscesses.
Actively Recruiting
This research aims to evaluate the effectiveness of bilateral Rhomboid Intercostal Block RIB for pain relief after elective bilateral breast prosthesis surgery. The study focuses on how this block might improve postoperative pain management and reduce the need for opioid pain medications. Eligible female patients aged 18 to 65 years with good physical health ASA status I-II will participate in this randomized, single-center trial. Participants will be randomly assigned to one of two groups. One group will receive an ultrasound-guided bilateral RIB block with a local anesthetic mixture before surgery, in addition to standard general anesthesia. The other group will undergo surgery with only standard general anesthesia and no regional block. All patients will receive postoperative pain control with intravenous tramadol administered by patient-controlled analgesia PCA. During the 24 hours after surgery, researchers will monitor total tramadol use, pain scores at specific time points, time to first pain medication request, need for additional pain relief, nausea and vomiting occurrence, and any complications related to the block. Assessments will be made at 0, 1, 2, 6, 12, and 24 hours postoperatively to understand the pain control effectiveness and safety of the RIB procedure.
Actively Recruiting
Researchers are conducting a randomized clinical trial to compare the clinical success and effects on periodontal tissues of band and loop space maintainers made with a three-dimensional printer versus those made by conventional methods. The study focuses on systemically healthy children who require bilateral lower deciduous first molar extraction and space maintainer application. The goal is to assess how these two types of space maintainers perform and affect gum health over time. The trial uses a split-mouth design where each child receives a band and loop space maintainer made by conventional technique on one side of the lower jaw and one made by a three-dimensional printer on the other side. Digital impressions will be taken with an intraoral scanner, and the 3D-printed space maintainer will be created using micro laser sinterisation from nickel-chromium metal powders. The conventional space maintainer will be made with traditional alginate impressions and stainless steel bands soldered in a laboratory. Participants will be followed for 18 months with check-ups every six months to monitor the survival and clinical success of each appliance, including criteria like cement dissolution, breakage, gum inflammation, and plaque buildup. Periodontal health will be evaluated through pocket depth, plaque index, gingival index, and tests of gingival groove fluid for inflammatory markers. Patient satisfaction with the impression methods will also be compared. Assessments will be repeated at baseline and during follow-up visits to understand the long-term effects of the space maintainers.
1-10 of 20
1